![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GENZYME CRITICIZED FOR ANORMED BID
GENZYME CRITICIZED FOR ANORMED BID
Genzyme Corp. is under fire from AnorMed Inc. shareholders. Last month, Cambridge, Mass.-based Genzyme made an unsolicited offer to purchase AnorMed, a Canadian developer of cancer and AIDS treatments.
Boston
Business Journal
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct